Lulu Yan Selected Research

Lulu Yan Research Topics

Disease

5	Infections 01/2021 - 12/2018
4	Neoplasms (Cancer) 01/2021 - 01/2008
3	Neoplasm Metastasis (Metastasis) 03/2011 - 01/2008
3	Adenocarcinoma of Lung 03/2011 - 01/2008
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022 - 01/2021
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2021
1	Oligohydramnios 05/2022
1	Multicystic Dysplastic Kidney (Multicystic Kidney) 05/2022
1	Hypoxia (Hypoxemia) 07/2021
1	Liver Failure 01/2021
1	Sudden Death 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Epilepsy (Aura) 01/2021
1	Aneuploidy (Aneuploid) 06/2020
1	Trisomy (Trisomies) 06/2020
1	Porokeratosis (Palmoplantar Porokeratosis) 07/2018
1	ST Elevation Myocardial Infarction 09/2017
1	Diabetes Mellitus 09/2017
1	Hyperlipidemias (Hyperlipidemia) 09/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2016
1	Inflammation (Inflammations) 09/2015
1	Ischemia 09/2015
1	Vascular Malformations 09/2015
1	Retinal Neovascularization 09/2015
1	Hyperplasia 07/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2013
1	Pathologic Neovascularization 12/2013
1	Melanoma (Melanoma, Malignant) 02/2011
1	Embolism (Embolus) 01/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2008
2	AlbuminsIBA 01/2022 - 07/2021
2	RNA (Ribonucleic Acid)IBA 07/2021 - 12/2013
2	Uric Acid (Urate)IBA 07/2021 - 09/2017
2	Oxygen (Dioxygen)IBA 07/2021 - 09/2015
2	Antimicrobial PeptidesIBA 01/2021 - 11/2019
2	Messenger RNA (mRNA)IBA 11/2019 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 09/2017 - 02/2011
2	Retinaldehyde (Retinal)IBA 09/2015 - 07/2015
2	Tissue Inhibitor of Metalloproteinase-2IBA 11/2009 - 01/2008
1	Nonsense Codon (Nonsense Mutation)IBA 05/2022
1	N-Methylaspartate (NMDA)IBA 01/2022
1	GlobulinsIBA 07/2021
1	Alanine Transaminase (SGPT)IBA 07/2021
1	Transaminases (Aminotransferases)IBA 07/2021
1	purineIBA 07/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Tripartite Motif ProteinsIBA 01/2021
1	Systemic carnitine deficiencyIBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	dichlorobis(azomycin)platinum IIIBA 06/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2018
1	Mevalonic Acid (Mevalonate)IBA 07/2018
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	LipidsIBA 09/2017
1	NitrogenIBA 09/2017
1	Urea (Carbamide)FDA LinkGeneric 09/2017
1	danshen dripping pillIBA 12/2016
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2016
1	MicroRNAs (MicroRNA)IBA 09/2015
1	Long Noncoding RNAIBA 12/2013
1	Untranslated RNA (Noncoding RNA)IBA 12/2013
1	Cisplatin (Platino)FDA LinkGeneric 03/2011
1	Matrix Metalloproteinases (MMPs)IBA 03/2011
1	formosanin CIBA 03/2011
1	Protein Subunit VaccinesIBA 02/2011
1	IpilimumabIBA 02/2011
1	Antineoplastic Agents (Antineoplastics)IBA 11/2009
1	Peptide Hydrolases (Proteases)FDA Link 01/2008
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2008
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2008

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Immunotherapy 01/2021
1	Percutaneous Coronary Intervention 09/2017